Cite
The Feasibility and Oncological Safety of Axillary Reverse Mapping in Patients with Breast Cancer: A Systematic Review and Meta-Analysis of Prospective Studies
MLA
Li Yang, et al. “The Feasibility and Oncological Safety of Axillary Reverse Mapping in Patients with Breast Cancer: A Systematic Review and Meta-Analysis of Prospective Studies.” PLoS ONE, vol. 11, no. 2, Jan. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....212b200173a23929bc452a13226c278e&authtype=sso&custid=ns315887.
APA
Li Yang, Chao Han, Mei-zhu Zheng, Ben Yang, Gang Zheng, & Wen-shu Zuo. (2016). The Feasibility and Oncological Safety of Axillary Reverse Mapping in Patients with Breast Cancer: A Systematic Review and Meta-Analysis of Prospective Studies. PLoS ONE, 11(2).
Chicago
Li Yang, Chao Han, Mei-zhu Zheng, Ben Yang, Gang Zheng, and Wen-shu Zuo. 2016. “The Feasibility and Oncological Safety of Axillary Reverse Mapping in Patients with Breast Cancer: A Systematic Review and Meta-Analysis of Prospective Studies.” PLoS ONE 11 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....212b200173a23929bc452a13226c278e&authtype=sso&custid=ns315887.